Paper41009494
Recent Developments in Osteoarthritis Research: Innovative Therapeutic Approaches and the Role of Polyphenols and Nanotechnology.
Vélez-Slimani H and 2 others. Int J Mol Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Recent Developments in Osteoarthritis Research: Innovative Therapeutic Approaches and the Role of Polyphenols and Nanotechnology. Papers, record 41009494. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009494
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Developments in Osteoarthritis Research: Innovative Therapeutic Approaches and the Role of Polyphenols and Nanotechnology.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Osteoarthritis | Major topic |
| Polyphenols | Major topic |
| Nanotechnology | Major topic |
| Humans | |
| Animals | |
| Drug Delivery Systems | |
| Nanoparticles |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1230553 | FONDECYT | PubMed | ||
| DIUFRO PP24-0003 | Universidad de La Frontera | PubMed |
Source PubMed
References164
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38485979 | Lifestyle behaviour changes associated with osteoarthritis: a prospective cohort study. | Sci Rep | 2024 | https://conductscience.org/library/papers/38485979 | PubMed |
| 2 | 32235300 | The Role of Chondrocyte Hypertrophy and Senescence in Osteoarthritis Initiation and Progression. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32235300 | PubMed |
| 3 | 30612087 | Knockdown of FOXM1 attenuates inflammatory response in human osteoarthritis chondrocytes. | Int Immunopharmacol | 2019 | https://conductscience.org/library/papers/30612087 | PubMed |
| 4 | 39899845 | Bioavailability of Food Polyphenols: Current State of Knowledge. | Annu Rev Food Sci Technol | 2025 | https://conductscience.org/library/papers/39899845 | PubMed |
| 5 | 27119082 | Polyphenols from Chilean Propolis and Pinocembrin Reduce MMP-9 Gene Expression and Activity in Activated Macrophages. | Biomed Res Int | 2016 | https://conductscience.org/library/papers/27119082 | PubMed |
| 6 | 34497523 | Aging, Cell Senescence, the Pathogenesis and Targeted Therapies of Osteoarthritis. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34497523 | PubMed |
| 7 | 39755397 | Osteoarthritis. | Lancet | 2025 | https://conductscience.org/library/papers/39755397 | PubMed |
| 8 | 40757100 | Osteoarthritis: Mechanisms and Therapeutic Advances. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40757100 | PubMed |
| 9 | 30653843 | A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. | Arthritis Rheumatol | 2019 | https://conductscience.org/library/papers/30653843 | PubMed |
| 10 | 39518447 | Beyond Boundaries of a Trial: Post-Market Clinical Follow-Up of SOYA Patients. | J Clin Med | 2024 | https://conductscience.org/library/papers/39518447 | PubMed |
| 11 | 27738491 | Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27738491 | PubMed |
| 12 | 37820754 | Activation of the Nrf-2 pathway by pinocembrin safeguards vertebral endplate chondrocytes against apoptosis and degeneration caused by oxidative stress. | Life Sci | 2023 | https://conductscience.org/library/papers/37820754 | PubMed |
| 13 | 39533324 | Small heterodimer partner-interacting leucine zipper protein suppresses pain and cartilage destruction in an osteoarthritis model by modulating the AMPK/STAT3 signaling pathway. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/39533324 | PubMed |
| 14 | 32035570 | Osteoarthritis: Pathology, Diagnosis, and Treatment Options. | Med Clin North Am | 2020 | https://conductscience.org/library/papers/32035570 | PubMed |
| 15 | 31278997 | OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. | Osteoarthritis Cartilage | 2019 | https://conductscience.org/library/papers/31278997 | PubMed |
| 16 | 31614911 | Proinflammatory Effects of IL-1β Combined with IL-17A Promoted Cartilage Degradation and Suppressed Genes Associated with Cartilage Matrix Synthesis In Vitro. | Molecules | 2019 | https://conductscience.org/library/papers/31614911 | PubMed |
| 17 | 39554475 | Bone marrow lesions in osteoarthritis: Characterising genetic and histological changes to understand disease pathophysiology. | Osteoarthr Cartil Open | 2024 | https://conductscience.org/library/papers/39554475 | PubMed |
| 18 | 36910270 | Intra-articular nanoparticles based therapies for osteoarthritis and rheumatoid arthritis management. | Mater Today Bio | 2023 | https://conductscience.org/library/papers/36910270 | PubMed |
| 19 | 40514670 | Proteomic analysis of hydrogen peroxide-treated human chondrocytes shows endoplasmic reticulum stress, cytoskeleton remodeling, and altered secretome composition. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40514670 | PubMed |
| 20 | 19604415 | The effect of caffeic acid phenethyl ester on the functions of human monocyte-derived dendritic cells. | BMC Immunol | 2009 | https://conductscience.org/library/papers/19604415 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942239 | Plant-Derived Polyphenols in Osteoarthritis: Mechanisms, Delivery Systems, and Therapeutic Synergy. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942239 | PubMed |
| 42885307 | Resveratrol alleviates osteoarthritis progression by inhibiting NLRP3 inflammasome response via the AMPK/PPARγ signaling pathway. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42885307 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009494
GET https://conductscience.org/api/papers/v1/41009494/references?page=2